Skip to main content
. 2021 Jan 11;379(1):4. doi: 10.1007/s41061-020-00318-2

Fig. 14.

Fig. 14

Comparison of severe acute respiratory syndrome coronavirus (SARS-CoV)-2 receptor binding domain (RBD)/human angiotensin-converting enzyme 2 (hACE2) complex structures (a) and the constructed SARS-CoV-2 RBD/hACE2 peptide complex (b). Image reproduced from Ref. [60] with permission from bioRxiv